ESMO COLLOQUIUM Sessions

ESMO COLLOQUIUM - Hepatocellular carcinoma treatment: Now, next and beyond

ESMO COLLOQUIUM - Systemic therapies in unresectable hepatocellular carcinoma (HCC): 1st and later lines

ESMO COLLOQUIUM - Immune check point inhibitors: Are we ready for combination?

ESMO COLLOQUIUM - Acute Myeloid Leukemia – Focus on FLT3-ITD mutation

ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?

*Resources are not available.

All ESMO 2018 Resources

Last update: 23 October 2018